Global Health Security: An Economic Mandate

In an interconnected world, the health of populations and the strength of economies are inseparable. As outbreaks cross borders within days, nations face not only humanitarian imperatives but also profound economic consequences.

Global health security (GHS) can no longer be viewed solely through the lens of charity. It demands investment, policy shifts, and a clear-eyed understanding of returns.

Economic Returns on GHS Investments

Between 2007 and 2022, U.S. public spending of $46 billion on global health research and development delivered a sixfold return on investment. This equates to $255 billion in economic benefits, including 600,000 U.S. jobs, $104 billion in economic activity, and $102 billion in industry investment.

Each dollar directed at neglected disease R&D has generated every dollar generates $405 return in social and health outcomes. Such figures underscore that GHS strengthens national security, enhances diplomatic influence, and safeguards prosperity by avoiding costly supply chain disruptions.

• 600,000 U.S. jobs supported by health R&D activity
• $104 billion in domestic economic stimulation
• $102 billion in private industry follow-on investment

Pandemic Economic Toll

Global economies lose an estimated $700 billion each year due to pandemics, with a 47–57% chance of another large-scale outbreak within 25 years. More alarming, pathogens spread globally in 36 hours, disrupting exports, labor markets, and consumer confidence.

The COVID-19 pandemic offered a stark demonstration: recessions, choked supply chains, and volatile financial markets. Without robust GHS, future crises threaten even deeper economic scarring.

Current Funding Trends and Gaps

Despite the clear stakes, U.S. annual GHS spending hovers around $1.5 billion—modest compared to a $60 billion foreign aid budget. Recent policy shifts favor bilateral, security-focused strategies that demand measurable returns, often at the expense of multilateral programs.

Globally, total health spending reached $9.8 trillion in 2021, representing 10.3% of GDP, driven by government and out-of-pocket expenditures. Yet aid to low-income nations remains vulnerable to inflation and debt pressures, undermining long-term GHS capacity.

• Annual U.S. GHS allocation: ~$1.5 billion
• Global health expenditure (2021): $9.8 trillion
• Risk of funding shortfalls from 2025 cuts

Risks of Underinvestment

Sustained funding cuts risk 9.4–22.6 million additional deaths by 2030. In the U.S., elimination of $11 billion in public health grants and $577 million in antiviral research has weakened readiness. The Global Fund’s current pledges fall short of an $18 billion target, while EU contributions face a 26.5% annual reduction.

Historical precedents are sobering: Trump-era cuts threatened 3 million extra HIV deaths, 107,000 more malaria fatalities, and 2 million additional TB deaths by 2025. Weakening GHS accelerates drug-resistant outbreaks that soon cross borders, fueling global economic losses.

Strategic Shifts and 2026 Opportunities

Geopolitical tensions are reshaping health diplomacy. Bilateral deals often deliver faster returns than multilateral commitments, but they risk fragmenting global preparedness. Development finance institutions are stepping in; the U.S. International Development Finance Corporation now provides loans and equity to build health infrastructure.

CEPI’s 3.0 initiative seeks $2.5 billion to develop 100-day vaccine platforms, while the 2026 UN High-Level Meeting will spotlight preparedness pledges. Yet the Global Health Security Index remains stagnant at 38.9/100 since 2019.

Proposals for a Sustainable Economic Mandate

Financing GHS need not break national budgets. Just 0.01% of GDP could fully fund the Global Fund ($6 billion/year), WHO ($2 billion), Gavi ($2 billion), and the Pandemic Fund ($1.5 billion). Investing in primary health care investment lays the groundwork for resilient communities.

• Integrate real-time risk monitoring of health, social, and economic data
• Mobilize private capital and DFI-driven models for infrastructure
• Engage communities in preparedness and response planning

The United States faces domestic challenges: 5 million may lose health insurance and 2 million SNAP benefits in 2026 if trends continue. These gaps weaken the foundation for global solidarity and heighten vulnerability to crises.

A Call to Action

Global health security is not an optional expenditure—it is an economic imperative. By reframing GHS as a driver of growth and stability, policymakers can unlock innovative funding mechanisms and forge bold partnerships.

In 2026, stakeholders must recommit: replenish multilateral funds, prioritize equity in manufacturing, and leverage data for early warning signals. Every nation has a stake in ensuring that disease outbreaks do not derail prosperity or claim avoidable lives.

Strong investments today will yield dividends in security, diplomatic influence, and economic resilience for generations to come. The time to act is now—because in a connected world, our shared future depends on the health of us all.